Time trends and geographic variations for thyroid cancer in New Caledonia, a very high incidence area (1985-1999)

European Journal of Cancer Prevention

Volumn 16, Issue 1, 2007, Pages 62-70

  Truong, Thérèse ^a   Rougier, Yannick ^b   Dubourdieu, Dominique ^c   Guihenneuc Jouyaux, Chantal ^a,d   Orsi, Laurent ^a   Hémon, Denis ^a   Guénel, Pascal ^a  

^a INSERM   (France)

^b Institut Pasteur de Nouvelle Caledonie Noumea   (New Caledonia)

^c Laboratory of Anatomy and Cytopathology   (New Caledonia)

^d CNRS   (France)

Author keywords

Incidence; New Caledonia; Thyroid neoplasms

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GEOGRAPHICAL VARIATION (SPECIES); HISTOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PACIFIC ISLANDER; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RISK FACTOR; SCREENING; THYROID CANCER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW CALEDONIA; THYROID NEOPLASMS;

EID: 33846203435     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000236244.32995.e1     Document Type: Article

References (36)

1. Akslen LA, Haldorsen T, Thoresen SO, Glattre E (1993). Incidence pattern of thyroid cancer in Norway: influence of birth cohort and time period. Int J Cancer 53:183-187.
2. Bacher-Stier C, Riccabona G, Totsch M, Kemmler G, Oberaigner W, Moncayo R (1997). Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 7:733-741.
3. Ballivet S, Salmi LR, Dubourdieu D, Bach F (1995). Incidence of thyroid cancer in New Caledonia, South Pacific, during 1985-1992. Am J Epidemiol 141:741-746.
4. Ballivet S, Salmi LR, Dubourdieu D (2000). Capture-recapture method to determine the best design of a surveillance system. Application to a thyroid cancer registry. Eur J Epidemiol 16:147-153.
5. Baumann F, Rougier Y (2005). Registre du cancer de Nouvelle- Calédonie, bilan de 15 années de surveillance, 1989-2003 (Cancer registry of New Caledonia, report of 15 years of surveillance, 1989-2003) [in French]. Bull Épidémiol Hebdomadaire 34:169-171.
6. Besag JE, York JC, Mollié A (1991). Bayesian image restoration with two applications in spatial statistics. Ann Inst Stat Math 43:1-59.
7. Breslow NE, Day NE (1987). Statistical methods in cancer research. Volume 2. The design and analysis of cohort studies. Lyon: IARC Scientific Publications.
8. Burgess JR (2002). Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1997). Thyroid 12:141-149.
9. Colonna M, Grosclaude P, Remontet L, Schvartz C, Mace-Lesech J, Velten M, et al. (2002). Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer 38:1762-1768.
10. dos Santos Silva I, Swerdlow AJ (1993). Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 67:330-340.
11. Ferlay J, Bray F, Pisani P, Parkin DM (2004). GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. Lyon: IARC Press.
12. Franceschi S, La Vecchia C, Bidoli E (1998). High incidence of thyroid cancer in central Italy [letter]. Int J Cancer 77:481-482.
13. Gaitan E (1990). Goitrogens in food and water. Annu Rev Nutr 10:21-39.
14. Gharib H, Goellner JR (1993). Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118:282-289.
15. Goodman MT, Yoshizawa CN, Kolonel LN (1988). Descriptive epidemiology of thyroid cancer in Hawaii. Cancer 61:1272-1281.
16. Hedinger C, Williams ED, Sobin LH (1988). Histological typing of thyroid tumours. New York, Berlin, Heidelberg: Springer-Verlag.
17. Hodgson NC, Button J, Solorzano CC (2004). Thyroid cancer: is the incidence still increasing? Ann Surg Oncol 11:1093-1097.
18. Hrafnkelsson J, Jonasson JG, Sigurdsson G, Sigvaldason H, Tulinius H (1988). Thyroid cancer in Iceland 1955-1984. Acta Endocrinol (Copenh) 118:566-572.
19. ITSEE-INSEE (1997). Recensement de la population de Nouvelle-Calédonie, principaux tableaux 1996 (Population census of New Caledonia, 1996) [in French]. Nouméa: ITSEE-INSEE.
20. Leenhardt L, Bernier MO, Boin-Pineau MH, Conte DB, Marechaud R, Niccoli-Sire P, et al. (2004a). Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 150:133-139.
21. Leenhardt L, Grosclaude P, Cherie-Challine L (2004b). Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14:1056-1060.
22. Liu S, Semenciw R, Ugnat AM, Mao Y (2001). Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer 85:1335-1339.
23. Mahoney MC, Lawvere S, Falkner KL, Averkin YI, Ostapenko VA, Michalek AM, et al. (2004). Thyroid cancer incidence trends in Belarus: examining the impact of Chernobyl. Int J Epidemiol 33:1025-1033.
24. Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES, Mandel SJ (2000). Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 133:696-700.
25. Paksoy N (1988). Frequency of thyroid cancer in Pacific populations. J Natl Cancer Inst 61:1272-1281.
26. Pottier D (1992). Population at risk. In: Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, editors. Cancer incidence in five continents. Vol VI. Lyon: IARC. pp. 174-177.
27. Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW (2005). Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 62:156-162.
28. Robertson C, Boyle P (1998). Age-period-cohort models of chronic disease rates. II: Graphical approaches. Stat Med 17:1325-1339.
29. Spielgelhalter DJ, Thomas A, Best NG (2001). WinBUGS version 1.4, user manual. London, UK: Medical Research Council Biostatistics Unit Cambridge, and Imperial College School of Medicine.
30. Spitz M, Sider JG, Katz RL, Pollack ES, Newell GR (1988). Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981. Int J Cancer 42:549-553.
31. Stewart BW, Kleihues P (2003). World cancer report. Lyon: IARC Press.
32. Truong T, Orsi L, Dubourdieu D, Rougier Y, Hemon D, Guenel P (2005). Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol 161:1056-1065.
33. Verkooijen HM, Fioretta G, Pache JC, Franceschi S, Raymond L, Schubert H, Bouchardy C (2003). Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14:13-17.
34. Wakefield JC, Best NG, Wallgren A (2000). Bayesian approaches to disease mapping. In: Elliot P, Wakefield JC, Best NG, Briggs DJ, editors. Spatial epidemiology, methods and applications. Oxford: Oxford University Press. pp. 104-127.
35. World Health Organization (1990). International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization.
36. Zheng T, Holford TR, Chen Y, Ma JZ, Flannery J, Liu W, et al. (1996). Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935-1992. Int J Cancer 67:504-509.